As per the report, the gene therapy market size was US$ 2.99 billion in 2021. It is projected to grow US$ 15.68 billion by 2030 at a CAGR of 20.2% in the forecast period.
The gene therapy is described as the treatment of an illness by changing, replacing, or supplementing a missing or defective genetic combination that is responsible for the disease. The gene therapy has become one of the most desirable research goals in the fight against degenerative illnesses. The need for gene therapy is being driven by an increase in the number of cases of cancer and other chronic diseases all across the world. The advancements in gene therapies are projected to be approved in the upcoming years, contributing to the gene therapy market’s growth during the forecast period.
Download the FREE Sample Report (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1462
Market Overview
A recent study by Precedence Research on the gene therapy market offers a forecast for 2021 and 2030. The study analyzes crucial trends that are currently determining the growth of the gene therapy market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of gene therapy. The study also provides the dynamics that are responsible for influencing the future status of this market over the forecast period.
A detailed assessment of the gene therapy market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the gene therapy market along with their product portfolio enhances the reliability of this comprehensive research study.
Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market
Key Points
- Primary Research
- Secondary Research
- Market Size Estimation
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Challenges
- Macroeconomic Indicators
- Technology Trends and Assessment
- Market Factor Analysis
- Porter’s Five Forces Analysis
- Bargaining Power Of Suppliers
- Bargaining Power Of Buyers
- Threat Of New Entrants
- Threat Of Substitutes
- Intensity Of Rivalry
- Value Chain Analysis
- Investment Feasibility Analysis
- Pricing Analysis
Research Methodology
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, the structure of the market participants and industry's competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
Industry participants involved in this research study include:
- CEOs, VPs, market intelligence managers
- Procuring and national sales managers technical personnel, distributors and resellers
- Research analysts and key opinion leaders from various domains
Competition Landscape
In the final section of the report on the global gene therapy market, a 'dashboard view' of the companies has been provided to compare the current market scenario and the contribution of companies to the global gene therapy market. Moreover, the report is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to segments of the global market. Report audiences can gain segment-specific manufacturer insights to identify and evaluate key competitors based on an in-depth assessment of their capabilities and success in the gene therapy marketplace.
Some of the prominent players in the global gene therapy market include:
- Dimension Therapeutics Inc.
- Taxus Cardium Pharmaceuticals Group Inc.
- Epeius Biotechnologies Corp.
- Shanghai Sunway Biotech Co. Ltd
- Applied Genetic Technologies Corporation
- Bristol-Myers Squibb Company
- American Gene Technologies
- BioMarin Pharmaceuticals Inc.
- Gensight Biologics S.A.
- Sibinono GeneTech Co. Ltd
Market Segmentation
Segments of the global gene therapy market have been analyzed in terms of their market share to understand an individual segment’s relative contribution to market growth. This detailed level of information is important for identifying key trends in the global gene therapy market.
Market Segments as below:
By Vector Type
- Viral Vector
- Non-viral Vector
By Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Receptors
- Others
By Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Diseases
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- LATAM
- Rest of the World
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Gene Therapy Market
5.1. COVID-19 Landscape: Gene Therapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Gene Therapy Market, By Vector
8.1. Gene Therapy Market, by Vector Type, 2021-2030
8.1.1. Viral Vector
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Non-viral Vector
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Gene Therapy Market, By Application
9.1. Gene Therapy Market, by Application, 2021-2030
9.1.1. Oncological Disorders
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Rare Diseases
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Cardiovascular Diseases
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Neurological Disorders
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Infectious Diseases
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Gene Therapy Market, By Gene
10.1. Gene Therapy Market, by Gene, 2021-2030
10.1.1. Antigen
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Cytokine
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Tumor Suppressor
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Suicide
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Deficiency
10.1.5.1. Market Revenue and Forecast (2019-2030)
10.1.6. Receptors
10.1.6.1. Market Revenue and Forecast (2019-2030)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Gene Therapy Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Vector (2019-2030)
11.1.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.3. Market Revenue and Forecast, by Gene (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Vector (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.4.3. Market Revenue and Forecast, by Gene (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Vector (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.3. Market Revenue and Forecast, by Gene (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Vector (2019-2030)
11.2.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.3. Market Revenue and Forecast, by Gene (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Vector (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.4.3. Market Revenue and Forecast, by Gene (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Vector (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.3. Market Revenue and Forecast, by Gene (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Vector (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.3. Market Revenue and Forecast, by Gene (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Vector (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.3. Market Revenue and Forecast, by Gene (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Vector (2019-2030)
11.3.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.3. Market Revenue and Forecast, by Gene (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Vector (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.4.3. Market Revenue and Forecast, by Gene (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Vector (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.3. Market Revenue and Forecast, by Gene (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Vector (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.3. Market Revenue and Forecast, by Gene (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Vector (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.3. Market Revenue and Forecast, by Gene (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Vector (2019-2030)
11.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.3. Market Revenue and Forecast, by Gene (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Vector (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.4.3. Market Revenue and Forecast, by Gene (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Vector (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.3. Market Revenue and Forecast, by Gene (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Vector (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.3. Market Revenue and Forecast, by Gene (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Vector (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.3. Market Revenue and Forecast, by Gene (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Vector (2019-2030)
11.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.3. Market Revenue and Forecast, by Gene (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Vector (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.4.3. Market Revenue and Forecast, by Gene (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Vector (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.3. Market Revenue and Forecast, by Gene (2019-2030)
Chapter 12. Company Profiles
12.1. Dimension Therapeutics Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Taxus Cardium Pharmaceuticals Group Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Epeius Biotechnologies Corp.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Shanghai Sunway Biotech Co. Ltd
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Applied Genetic Technologies Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Bristol-Myers Squibb Company
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. American Gene Technologies
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. BioMarin Pharmaceuticals Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Gensight Biologics S.A.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Sibinono GeneTech Co. Ltd
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Why Buy this Report?
The purpose of Precedence Research's gene therapy market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1462
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments